01 May 2004
Quality and safety of organ transplantation.
Kaija SalmelaAnn Transplant 2004; 9(1): 51-52 :: ID: 142792
Abstract
Transplantation, like all medical procedures, carries potential risks forboth donors, recipients and health care personnel. Living donation and associated morbidity and mortalityare documented in living donor registries which, run nationally, are a step toward long-term qualitycontrol in organ transplantation. Such quality control and management should however be a part of allstages of the transplantation process, beginning with donor identification and ending with long-termfollow up of transplant recipients. A whole range of transplantation-related events would be controlled,including organ procurement, handling, risk of disease/malignancy transmission, recipient operation andfollow up. Several international bodies and institutions have formulated statements addressing theseissues. The essential ideas of these documents are focused on protection of human integrity, avoidanceof bodily harm and coercion, exclusion of commercialism, equitable access to transplantation, fairnessof allocation, transparency of the allocation criteria/procedures, competence requirements of the staffand quality management.
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






